DSTYK and paraplegia: Previous studies reported that patients with a large intragenic deletion of DSTYK as the genetic basis for Spastic Paraparesis type 23 (SPG23), an autosomal-recessive disorder characterized by progressive spastic paraplegia and skin pigment abnormalities58.